Lipotropic injections can be administered in the thigh muscle, hip muscle, upper arm muscle, and buttocks
Wegovy EPAR product information (PDF)
The primary outcome measures clinical remission using mMS at 12 weeks, while secondary endpoints include endoscopic remission, clinical response, and safety parameters, with the study having started in December 2024 and estimated completion in June 2028 across 52 locations in the US and Europe
Participants adherent to tirzepatide treatment and achieving 5% weight loss by primary endpoint (week 72 SURMOUNT1
"Wegovy and Mounjaro are both clinically effective, but they work differently and suit different patients
Before treatment Before treatment I was skeptical about starting a prescription weight loss medication but it has exceeded my expectations